- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Vitamins&Nutrition Prod
Snapshot for ImmunoBiotics Inc (IMBI)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.0280 | 52wk Range: | 0.0280 - 0.1000 | 1-Yr Rtn: | - |
Key Statistics for IMBI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0300 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 23.46 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IMBI
No data available
Company Profile & Key Executives for IMBI
ImmunoBiotics, Inc. develops and markets nutraceuticals. The Company licenses to other companies the rights to manufacture, develop, market, distribute and sell its products.
| Thomas P LaheyChairman/COO | Daniel J SmithPresident/CEO |
| Vithal J RajadyakshaVP/CFO/Treasurer/Secy |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IMBI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page